Literature DB >> 15380396

Alterations in platelet serotonin transporter binding in women with postpartum onset major depression.

D Jeffrey Newport1, Michael J Owens, David L Knight, Kim Ragan, Neal Morgan, Charles B Nemeroff, Zachary N Stowe.   

Abstract

There is considerable debate as to whether postpartum depression (PPD) is biologically distinct from other depressive syndromes. Although abnormalities in serotonergic neural systems have repeatedly been reported in depression, few such studies have been conducted in PPD. In the present study, platelet serotonin transporter (SERT) binding was assessed using [(3)H]paroxetine in 14 depressed pregnant women, 31 normal healthy pregnant women, 39 depressed postpartum women, and 27 normal healthy postpartum women; all of the subjects were drug-free. Significant differences were detected among the 4 groups with respect to the dissociation constant (Kd) of platelet binding sites for [(3)H]paroxetine with the highest Kd values among those with PPD. The density (Bmax) of platelet binding sites for [(3)H]paroxetine did not differ between the study groups. These data suggest that PPD may be associated with unique alterations in serotonergic function that are specific to the puerperium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380396     DOI: 10.1016/j.jpsychires.2004.01.011

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  16 in total

1.  Successful treatment of epilepsy with serotonin reuptake inhibitors: proposed mechanism.

Authors:  C Albano; A Cupello; P Mainardi; S Scarrone; E Favale
Journal:  Neurochem Res       Date:  2006-05-13       Impact factor: 3.996

Review 2.  The role of tryptophan metabolism in postpartum depression.

Authors:  Kai-Ming Duan; Jia-Hui Ma; Sai-Ying Wang; ZhengDong Huang; YingYong Zhou; HeYa Yu
Journal:  Metab Brain Dis       Date:  2018-01-06       Impact factor: 3.584

3.  Postpartum Lactation-Mediated Behavioral Outcomes and Drug Responses in a Spontaneous Mouse Model of Obsessive-Compulsive Disorder.

Authors:  Swarup Mitra; McKenzie Mucha; Savanah Owen; Abel Bult-Ito
Journal:  ACS Chem Neurosci       Date:  2017-10-05       Impact factor: 4.418

4.  Platelet serotonin levels support depression scores for women with postpartum depression.

Authors:  Elisabeth Maurer-Spurej; Cheryl Pittendreigh; Shaila Misri
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

Review 5.  Emerging risk factors for postpartum depression: serotonin transporter genotype and omega-3 fatty acid status.

Authors:  Gabriel D Shapiro; William D Fraser; Jean R Séguin
Journal:  Can J Psychiatry       Date:  2012-11       Impact factor: 4.356

6.  Binding of paroxetine to the serotonin transporter in membranes from different cells, subcellular fractions and species.

Authors:  A Cupello; C Albano; E Gatta; S Scarrone; E Villa; G Zona
Journal:  Neurochem Res       Date:  2008-06-18       Impact factor: 3.996

Review 7.  Perinatal depression: treatment options and dilemmas.

Authors:  Teri Pearlstein
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

Review 8.  Postpartum depression.

Authors:  Teri Pearlstein; Margaret Howard; Amy Salisbury; Caron Zlotnick
Journal:  Am J Obstet Gynecol       Date:  2009-04       Impact factor: 8.661

9.  A serotonin transporter gene polymorphism predicts peripartum depressive symptoms in an at-risk psychiatric cohort.

Authors:  Elisabeth B Binder; D Jeffrey Newport; Elizabeth B Zach; Alicia K Smith; Todd C Deveau; Lori L Altshuler; Lee S Cohen; Zachary N Stowe; Joseph F Cubells
Journal:  J Psychiatr Res       Date:  2009-12-31       Impact factor: 4.791

Review 10.  Precision medicine in perinatal depression in light of the human microbiome.

Authors:  Beatriz Peñalver Bernabé; Pauline M Maki; Shannon M Dowty; Mariana Salas; Lauren Cralle; Zainab Shah; Jack A Gilbert
Journal:  Psychopharmacology (Berl)       Date:  2020-02-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.